Impax Laboratories News

News on Impax Laboratories (Ticker: IPXL) continually updated from thousands of sources around the net.

10 hrs ago | Seeking Alpha

4 Reasons To Buy Impax Laboratories

Impax Laboratories is a technology-based specialty pharmaceutical company, with controlled-release and other in-house development and formulation expertise.

Comment?

Wed May 23, 2012

Benzinga

Top 4 Small-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest Profit Margin

Below are the top small-cap drug manufacturers-major stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin.

Comment?

Tue May 22, 2012

Freshnews

Impax Laboratories Announces Voting Results from 2012 Annual Meeting of Stockholders

HAYWARD, Calif. -- -- Impax Laboratories, Inc. held its 2012 Annual Meeting of Stockholders today in San Mateo, California.

Comment?

Thu May 10, 2012

Freshnews

Impax Laboratories to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

HAYWARD, Calif. -- -- Impax Laboratories, Inc. today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, at 10:40 a.m. PT.

Comment?

Wed May 02, 2012

AmericanBankingNews.com

Needham & Company Reiterates "Hold" Rating on Impax Laboratories

's stock had its "hold" rating restated by analysts at Needham & Company in a research report issued to clients and investors on Wednesday.

Comment?

Tue May 01, 2012

Reuters

UPDATE 1-Impax Labs profit rises on strong Adderall sales

Specialty pharmaceutical company Impax Laboratories Inc's quarterly profit beat analysts expectations as sales of its generic versions of attention deficit hyperactivity disorder drug Adderall rose nearly 50 percent.

Comment?